Cholera Oral Vaccine from Mexico
Inactivated oral vaccine with recombinant B-subunit and killed whole cells for cholera prevention in travelers. HTS 3002.49.0050 applies as an 'other' microbial culture-based vaccine for prophylactic human use. Not yeast-derived, fitting chapter exclusions.
Duty Rate — Mexico → United States
0%
Rate breakdown
9903.05.860%Universal product exemption (U.S. note 52(b))
Import Tips
• File FDA prior notice 72 hours pre-arrival; ensure tamper-evident packaging for oral suspension
• Provide WHO prequalification if available; document GMO status for biotech-derived components